noom reviews glp-1 jumps into off-brand weight loss drug market Noom’s New Microdose GLP-1 Program
Description
For many patients who previously had limited success with traditional interventions, these results represent a major breakthrough
Specific concerns: Skin reactions
Code availability The published article includes all data generated or analyzed during this study
The JAMA Network Open Study Study Design Database: TriNetX, which contains records from millions of U.S
Another issue involves patient expectations
